FIELD: medicine. SUBSTANCE: invention relates to an anti-exudative preparation used for infusion and irrigation of human body vessels and tissues comprising phospholipids and/or their derivatives, ketanols and/or their derivatives and membrane glycopeptides and/or their derivatives, buffer salts with pH = 7.2-7.4 and osmomolality value 200-400 and water taken in the definite ratio. An anti-exudative preparation is designated for prophylaxis of exudative symptoms in cavity surgery, vascular surgery and for irrigation of human body tissues. EFFECT: valuable properties of preparation, prolonged anti-exudative effect. 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ACTIVATING CORNEA ENDOTHELIUM PROLIFERATION BY APPLYING GLECOMEN SOLUTION | 1999 |
|
RU2151580C1 |
METHOD FOR REPAIRING CORNEAL ENDOTHELIUM | 2000 |
|
RU2165749C1 |
PHARMACEUTICAL COMPOSITION FOR MEDICINAL PUPIL OF EYE MYDRIASIS IN OPHTHALMOLOGY | 1999 |
|
RU2148404C1 |
PHARMACEUTICAL COMPOSITION "POLYANESTHETIC" FOR PROLONGED ANESTHETIZATION IN OPHTHALMOLOGY | 2001 |
|
RU2183114C1 |
PREPARATION FOR HEALING DISEASE AND DAMAGE OF CORNEA | 2000 |
|
RU2179026C1 |
METHOD FOR FINISHING EYE IMPLANTS AND CONTACT LENSES | 1998 |
|
RU2142257C1 |
OPHTHALMIC DROP "KARNOSIN" | 2001 |
|
RU2201213C1 |
PHARMACEUTICAL COMPOSITION FOR ANESTHESIA IN OPHTHALMOLOGY | 1999 |
|
RU2147876C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING CORNEAL EDEMAS | 2001 |
|
RU2197923C1 |
PHARMACEUTICAL COMPOSITION FOR ANALGESIA AND DECREASE OF INFLAMMATION IN OPHTHALMOLOGY | 2000 |
|
RU2173990C1 |
Authors
Dates
2002-07-20—Published
2000-07-06—Filed